Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Halozyme Therapeutics presents recombinant human proteins with collagenolytic effects

May 30, 2011

Sulfated hyaluronic acid shows preclinical promise to treat prostate cancer

May 30, 2011

Active Biotech's ABR-215757 improves SLE symptoms in exploratory phase II trial

May 27, 2011

FLAME study shows enhanced stroke recovery with fluoxetine

May 27, 2011

Nexvax-2 vaccine is safe and bioactive in phase I trial in celiac disease

May 27, 2011

Findings disclosed from two phase II trials of NXL-104/ceftazidime

May 27, 2011

Preclinical data support further development of PF-4348235 for treatment of COPD

May 27, 2011

LIPN gene mutation correlates with late-onset autosomal recessive ichthyosis

May 27, 2011

Monoclonal antibody against beta-amyloid reduces symptoms of AMD in vivo

May 26, 2011

New selective glucocorticoid receptor antagonists prevent olanzapine-induced weight gain in vivo

May 26, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...